Cargando…
Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
Lung cancer has the highest incidence of morbidity and mortality throughout the globe. A large number of patients are diagnosed with lung cancer at the later stages of the disease. This eliminates surgery as an option and places complete dependence on radiotherapy or chemotherapy, and/or a combinati...
Autores principales: | Zulfiqar, Bilal, Farooq, Asim, Kanwal, Shahzina, Asghar, Kashif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742438/ https://www.ncbi.nlm.nih.gov/pubmed/36518665 http://dx.doi.org/10.3389/fphar.2022.1035171 |
Ejemplares similares
-
Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
por: Farooq, Asim, et al.
Publicado: (2023) -
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
por: Asghar, Kashif, et al.
Publicado: (2017) -
Current Status of Immunotherapy for Lung Cancer and Future Perspectives
por: Kim, Ho Cheol, et al.
Publicado: (2020) -
Current status of immunotherapy for non-small cell lung cancer
por: Yang, Tao, et al.
Publicado: (2022) -
Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
por: Asghar, Kashif, et al.
Publicado: (2021)